Works matching AU Matthews, David R.
Results: 109
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2015, v. 38, n. 1, p. 140, doi. 10.2337/dc14-2441
- By:
- Publication type:
- Article
Cyclical variation in HbA1c values during the year: clinical and research implications.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Cyclical Variation in HbA<sub>1c</sub> Values During the Year: Clinical and Research Implications.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2.
- Published in:
- Diabetes Care, 2013, v. 36, n. 8, p. 2324, doi. 10.2337/dc12-0607
- By:
- Publication type:
- Article
Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Monitoring of Individual Needs in Diabetes (MIND)-2.
- Published in:
- Diabetes Care, 2012, v. 35, n. 11, p. 2128, doi. 10.2337/dc11-1326
- By:
- Publication type:
- Article
Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35: 1364-1379.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2012, v. 35, n. 6, p. 1364, doi. 10.2337/dc12-0413
- By:
- Publication type:
- Article
Monitoring of Individual Needs in Diabetes (MIND): Baseline Data From the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND Study.
- Published in:
- Diabetes Care, 2011, v. 34, n. 3, p. 601, doi. 10.2337/dc10-1552
- By:
- Publication type:
- Article
Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy.
- Published in:
- Diabetes Care, 2010, v. 33, n. 4, p. 730, doi. 10.2337/dc09-1867
- By:
- Publication type:
- Article
Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis.
- Published in:
- Diabetes Care, 2009, v. 32, n. 6, p. 1020, doi. 10.2337/dc08-1925
- By:
- Publication type:
- Article
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2009, v. 32, n. 1, p. 84, doi. 10.2337/dc08-1355
- By:
- Publication type:
- Article
Grand challenges in chronic non-communicable diseases.
- Published in:
- Nature, 2007, v. 450, n. 7169, p. 494, doi. 10.1038/450494a
- By:
- Publication type:
- Article
Wednesday, may 17, broadway ballroom north, 7:00 am to 9:00 am. recent clinical trials in hypertension: Tight blood pressure control in the UKPDS.
- Published in:
- American Journal of Hypertension, 2000, v. 13, p. 325A, doi. 10.1016/S0895-7061(00)00871-2
- By:
- Publication type:
- Article
Insulin resistance and β-cell function – a clinical perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2001, v. 3, p. S28, doi. 10.1046/j.1463-1326.2001.00029.x
- By:
- Publication type:
- Article
Assessment of the effects of insulin secretagogues in humans.
- Published in:
- Diabetes, Obesity & Metabolism, 2000, v. 2, n. 5, p. 271, doi. 10.1046/j.1463-1326.2000.00088.x
- By:
- Publication type:
- Article
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 4, p. 1103, doi. 10.1093/cvr/cvab128
- By:
- Publication type:
- Article
Oral Hydrocortisone Administration in Children with Classic 21-Hydroxylase Deficiency Leads to More Synchronous Joint GH and Cortisol Secretion.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 5, p. 2238, doi. 10.1210/jcem.87.5.8503
- By:
- Publication type:
- Article
Serum Cortisol and 17-Hydroxyprogesterone Interrelation in Classic 21-Hydroxylase Deficiency: Is Current Replacement Therapy Satisfactory?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 10, p. 4679, doi. 10.1210/jcem.86.10.7972
- By:
- Publication type:
- Article
Joint Growth Hormone and Cortisol Spontaneous Secretion Is More Asynchronous in Older Females Than in Their Male Counterparts.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 7, p. 3393, doi. 10.1210/jcem.86.7.7695
- By:
- Publication type:
- Article
Physiological Implications of Pulsatile Hormone Secretion.
- Published in:
- Annals of the New York Academy of Sciences, 1991, v. 618, n. 1, p. 28, doi. 10.1111/j.1749-6632.1991.tb27235.x
- By:
- Publication type:
- Article
The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national survey.
- Published in:
- Clinical & Experimental Hypertension, 2014, v. 36, n. 7, p. 484, doi. 10.3109/10641963.2013.863321
- By:
- Publication type:
- Article
High rates of child hypertension associated with obesity: a community survey in China, India and Mexico.
- Published in:
- Paediatrics & International Child Health, 2014, v. 34, n. 1, p. 43, doi. 10.1179/2046905513Y.0000000079
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors: A paradigm shift in treatment for type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, p. 3, doi. 10.1111/dom.15963
- By:
- Publication type:
- Article
Effects of sodium‐glucose co‐transporter‐2 inhibitors by background cardiovascular medications: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3020, doi. 10.1111/dom.15200
- By:
- Publication type:
- Article
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 106, doi. 10.1111/dom.14555
- By:
- Publication type:
- Article
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525
- By:
- Publication type:
- Article
Ultra‐rapid‐acting insulins for adults with diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2395, doi. 10.1111/dom.14461
- By:
- Publication type:
- Article
Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2116, doi. 10.1111/dom.14451
- By:
- Publication type:
- Article
Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 822, doi. 10.1111/dom.14291
- By:
- Publication type:
- Article
Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 245, doi. 10.1111/dom.14192
- By:
- Publication type:
- Article
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143
- By:
- Publication type:
- Article
ADVANCE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 3, doi. 10.1111/dom.14014
- By:
- Publication type:
- Article
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 530, doi. 10.1111/dom.13920
- By:
- Publication type:
- Article
Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 335, doi. 10.1111/dom.13899
- By:
- Publication type:
- Article
A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2240, doi. 10.1111/dom.13800
- By:
- Publication type:
- Article
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 454, doi. 10.1111/dom.13538
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 188, doi. 10.1111/dom.13484
- By:
- Publication type:
- Article
Semaglutide for type 2 diabetes mellitus: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2255, doi. 10.1111/dom.13361
- By:
- Publication type:
- Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
- By:
- Publication type:
- Article
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829
- By:
- Publication type:
- Article